ACETAZOLAMIDE

Product NDC
59651-905
11-digit product format
596510905
Labeler code
59651
Product ID
59651-905_0392e11a-1290-442f-9765-e1f79ec43eae
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ACETAZOLAMIDE
Dosage form
TABLET
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA212089
Marketing category
ANDA
Marketing start
2025-05-30
Substance
ACETAZOLAMIDE
Active strength
125 mg/1
Pharmacologic classes
Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A212089-001ACETAZOLAMIDEACETAZOLAMIDE125MGTABLET / ORALAB2025-05-30
A212089-002ACETAZOLAMIDEACETAZOLAMIDE250MGTABLET / ORALAB2025-05-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A212089-001AB
A212089-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A212089-001ACETAZOLAMIDE125MGTABLET / ORALAB2025-05-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02A212089-002ACETAZOLAMIDE250MGTABLET / ORALAB2025-05-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A212089-001ACETAZOLAMIDE125MGTABLET / ORALAB2025-05-3031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A212089-002ACETAZOLAMIDE250MGTABLET / ORALAB2025-05-3031067a03dcf5…
2025-08-23 18:47 UTC2025-08A212089-001ACETAZOLAMIDE125MGTABLET / ORALAB2025-05-306a471c1ec25d…
2025-08-23 18:47 UTC2025-08A212089-002ACETAZOLAMIDE250MGTABLET / ORALAB2025-05-306a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A212089-001ACETAZOLAMIDE125MGTABLET / ORALAB2025-05-30a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A212089-002ACETAZOLAMIDE250MGTABLET / ORALAB2025-05-30a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A212089-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A212089-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A212089-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A212089-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A212089-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A212089-002AB16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A212089-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A212089-002AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
ACETAZOLAMIDE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ACETAZOLAMIDE125 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
O3FX965V0IInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
197303Internal RxNorm lookup
197304Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
513da48f-8f12-4696-b862-e8d882bf8611Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
94b5d997-68ee-d92e-7c04-a34fdb427a66Product name920240509
d0adda24-c2d3-39f8-a845-ede9cd56b2c4Product name620210513
91efc97d-7785-4097-b6cf-4201369f41ebProduct name320190711

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59651-905-01ACETAZOLAMIDE100 in 1 BOTTLETABLET1002

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59651-905-01EA - Each59651-90536325896-08e3-4bd6-845c-80ac8ad0b85c12025-10-14

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ACETAZOLAMIDEACETAZOLAMIDEAurobindo Pharma Limited513da48f-8f12-4696-b862-e8d882bf86112025-11-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 212089
application number: ANDA212089
ndc (product): 59651-905

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
197303acetaZOLAMIDE 125 MG Oral TabletPSN513da48f-8f12-4696-b862-e8d882bf86112
197304acetaZOLAMIDE 250 MG Oral TabletPSN513da48f-8f12-4696-b862-e8d882bf86112
197303acetazolamide 125 MG Oral TabletSCD513da48f-8f12-4696-b862-e8d882bf86112
197304acetazolamide 250 MG Oral TabletSCD513da48f-8f12-4696-b862-e8d882bf86112

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
59651-905-0159651090501100 TABLET in 1 BOTTLE (59651-905-01) 100 tablet2025-05-30NoNoCurrent